Report on BOYDSense in "le Magazine de la santé"
France 5 presents the diabetes monitoring device from BOYDSense
In France, more than 3.9 million persons suffer from diabetes.
BOYDSense, the Alpha MOS subsidiary dedicated to medical applications, works on a pain-free device to monitor glucose levels with exhaled breath.
Along with Toulouse CHU, a clinical study has been conducted on 130 patients with Type-2 that measured their glucose level by blood analysis and breath analysis.
Dr. Pierre Gourdy, who is the investigator of the study comments: “More than 98% of the values showed high correlation between blood testing and breath measurement. The results are very promising.”
See the report in the Magazine de la santé on France 5 - June 16, 2023 (10:34)